A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Plenary Session
Meeting: ASCO Plenary Series
Session Title: ASCO Plenary Series: February 2022 Session
Track: Breast Cancer

Discussion of Abstract 360922: A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Plenary Session
Meeting: ASCO Plenary Series
Session Title: ASCO Plenary Series: February 2022 Session
Track: Breast Cancer

Panel Question and Answer With Drs. Ng, Strickler, and Chiorean

Plenary Session
Meeting: ASCO Plenary Series
Session Title: ASCO Plenary Series: February 2022 Session
Track: Breast Cancer

This site is intended for healthcare professionals in Europe and Japan only.

The selection of ASCO content on this site was made by the ASCO Publication and Education teams. Springer Healthcare selected the experts for interview. All content is made available solely for educational and informational purposes and personal use only.

© 2023 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

This program is supported by an educational grant from Daiichi Sankyo and brought to you by Springer Healthcare | Contact Us | Privacy Policy

Before you go....

We'd love your feedback!

Your feedback will help guide us in the next phase of this program. Please take a few minutes (estimated 2 minutes) to answer the following 6 questions.